Budesonide Turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma

Allergy and Asthma Proceedings

Volumn 24, Issue 2, 2003, Pages 129-136

  Banov, Charles ^a   Howland III, William C ^b   Lumry, William R ^c   Parasuraman, Bhash ^d   Uryniak, Thomas ^d   Liljas, Bengt ^e  

^a Allerg and Asthma Centers of C   (United States)

^b Allergy and Asthma Associates   (United States)

^c Allergy And Asthma Research Associates Texas   (United States)

^d ASTRAZENECA   (United Kingdom)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BUDESONIDE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; EMOTION; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON STEROID DEPENDENT ASTHMA; POWDER INHALER; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CIRCADIAN RHYTHM; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PEAK EXPIRATORY FLOW RATE; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STATISTICS; TREATMENT OUTCOME;

EID: 0042420374     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Okamoto LJ, Noonan M, DeBoisblanc BP, et al. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. Ann Allergy Asthma Immunol 76:455-461, 1996.
2. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Publication No. 97-4051, NIH/National Heart, Lung, and Blood Institute, Bethesda, MD, April 1997.
3. Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 101:457-463, 1998.
4. Kemp J, Wanderer AA, Ramsdell J, et al. Rapid onset of control with budesonide TURBUHALER in patients with mild to moderate asthma. Ann Allergy Asthma Immunol 82:463-471, 1999.
5. Nelson HS, Bernstein IL, Fink J, et al. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. Chest 113:1264-1271, 1998.
6. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 261: 3273-3277, 1989.
7. Kruse W, Eggert-Kruse W, Rampmaier J, et al. Dosage frequency and drug-compliance behaviour - a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 41:589-592, 1991.
8. Pullar T, Birtwell AJ, Wiles PG, et al. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 44:540-545, 1988.
9. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 150:1881-1884, 1990.
10. Farmer KC, Jacobs EW, and Phillips CR. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther 16:316-326, 1994.
11. Mann M, Eliasson O, Patel K, et al. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest 101:496-499, 1992.
12. Campbell LM, Watson DG, Venables TL, et al. Once daily budesonide Turbuhaler compared with placebo as initial prophylactic therapy for asthma. Br J Clin Res 2:111-122, 1991.
13. Jones AH, Langdon CG, Lee PS, et al. Pulmicort Turbuhaler once dally as initial prophylactic therapy for asthma. Respir Med 88:293-299, 1994.
14. McFadden ER, Casale TB, Edwards TB, et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J Allergy Clin Immunol 104:46-52, 1999.
15. Huss K, Naumann PL, Mason PJ, et al. Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol 86:524-530, 2001.
16. Reichenberg K, and Broberg AG. Quality of life in childhood asthma: use of the Paediatric Asthma Quality of Life Questionnaire in a Swedish sample of children 7 to 9 years old. Acta Paediatr 89:989-995, 2000.
17. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47:76-83, 1992.
18. Banov C, Howland WC III, and Lumry WR. The efficacy and safety of once-daily budesonide inhalation powder administered via Turbuhaler to adults with persistent asthma. Ann Allergy Asthma Immunol 86:627-632, 2001.
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-244, 1987.
20. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 47:81-87, 1994.
21. Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomised trials. BMJ 316:690-693, 1998.
22. Rowe BH, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department. A randomized controlled trial. JAMA 281:2119-2126, 1999.
23. Juniper EF. Quality of life in adults and children with asthma and rhinitis. Allergy 52:971-977, 1997.
24. Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the asthma quality of life questionnaire. Chest 115:1265-1270, 1999.
25. Rutten-van Mölken MPMH, Custers F, Van Doorslaer EKA, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 8:888-898, 1995.
26. Juniper EF, Svensson K, O'Byrne PM, et al. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 14:1038-1043, 1999.